Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants

BACKGROUND AND AIMS: This was a safety and efficacy pharmacogenetic study of a previously performed randomized trial which compared the effectiveness of treatment of hepatitis C virus infection with pegylated interferon alpha (pegIFNα) 2a vs. 2b, both with ribavirin, for 48 weeks, in HCV-HIV coinfec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vidal, Francesc, López-Dupla, Miguel, Laguno, Montserrat, Veloso, Sergi, Mallolas, Josep, Murillas, Javier, Cifuentes, Carmen, Gallart, Lluis, Auguet, Teresa, Sampériz, Gloria, Payeras, Antoni, Hernandez, Pilar, Arnedo, Mireia, Gatell, Josep Ma, Richart, Cristóbal
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2012
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487790/
https://ncbi.nlm.nih.gov/pubmed/23133602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0047725
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items